MedTrace Logo

A Comparison of the Intubating Laryngeal Mask FASTRACH™ and the Intubating Laryngeal Mask Ambu Aura-i™

NCT03109678 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2017-04-12

No results posted yet for this study

Summary

The intubating laryngeal mask Fastrach™ is considered a gold standard for blind intubation as well as for fibreoptic guided intubation via a laryngeal mask. Recently, a single use version of the mask has been introduced. The Fastrach single use laryngeal mask is beng compared to the new, low-priced single use intubating laryngeal mask Ambu Aura-i™.

Conditions

  • Airway Management
  • Laryngeal Mask Airway
  • Fibreoptic Intubation

Interventions

DEVICE

Crossover Ambu Aura-i™ / Rüsch Super Safety Silk™

After unsuccessful blind intubation in the Ambu Aura-i™ / Rüsch Super Safety Silk™ group: crossover design using the Ambu Aura-i™ mask in combination with the LMA ETT™ tracheal tube

DEVICE

Crossover Ambu Aura-i™ / LMA ETT™

After unsuccessful blind intubation in the Ambu Aura-i™ / LMA ETT group: crossover design using the Ambu Aura-i™ mask in combination with the Rüsch Super Safety Silk™ tracheal tube

DEVICE

Crossover FASTRACH™ / Rüsch Super Safety Silk™

After unsuccessful blind intubation in the FASTRACH™ / Rüsch Super Safety Silk™ group: crossover design using the FASTRACH™ mask in combination with the LMA ETT™ tube

DEVICE

Crossover FASTRACH™ / LMA ETT™

After unsuccessful blind intubation in the FASTRACH™ / LMA ETT™ group: crossover design using the FASTRACH™ mask in combination with the Rüsch Super Safety Silk™ tube

Sponsors & Collaborators

  • University of Kiel

    collaborator OTHER

  • Asklepios Kliniken Hamburg GmbH

    lead OTHER

Principal Investigators

  • Berthold Bein, Prof. Dr. · Asklepios Kliniken Hamburg GmbH

Study Design

Allocation
RANDOMIZED
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
15 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-12
Primary Completion
2012-03-07
Completion
2012-03-07

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03109678 on ClinicalTrials.gov